TGFB1 and neoplasm: In summary (Figure 3), we hypothesize that emerging tumour cells produce releasing transforming growth factor β (TGF-β), which acts on the fibroblasts via the TGFB1 receptor; this could completely switch off the actual canonical pathway in the fibroblasts.